ArticleBritish journal of cancer2019

Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.

Martina Magni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.